A new review in Cellular and Molecular Life Sciences maps the molecular pathways, immune microenvironment and AI-driven ...

A study of nearly 32,000 women in Shaanxi, China, found an overall HPV prevalence of 21.46 percent and showed that women ...

Each year, an estimated six million women in the United States acquire a high-risk HPV infection — and there are no FDA-approved treatments DARE-HPV development is backed by a $10 million U.S.

HPV vaccination before pregnancy was linked to lower preterm birth risk. Benefits were greater in women vaccinated at younger ages. The findings suggest HPV vaccination may help beyond cancer ...

Investing.com -- Dare Bioscience Inc (NASDAQ:DARE) shares rose 2.8% on Monday following the announcement that the company received a new U.S. patent for its HPV treatment program. Still guessing which ...

Findings from a nationwide study suggest HPV vaccination may reduce adverse pregnancy outcomes, emphasizing its importance in ...

A national case-control study from Sweden showed lower risks of preterm, very preterm, or spontaneous preterm birth in women ...

Cancer prevention discussions usually focus on smoking, alcohol consumption, diet, exercise, and screening. However, ...